Helex
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Pennsylvania Plz Fl 9, New York City, ...Website
helex.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Helex
Helex is a biotechnology company headquartered in New York, New York, developing genomic medicines for kidney diseases. Founded in 2021, the company focuses on creating gene editing therapeutics specifically designed for renal indications. Helex combines proprietary lipid nanoparticle technology for targeted delivery to the kidney with its Epic-Cure technology platform, which utilizes data-driven deep-learning modeling to design and validate guide RNAs for CRISPR-based gene editing. The platform enables precise drug design by predicting edit outcomes to ensure safety and avoid unwanted editing in non-target cells. The company's therapeutic focus includes Autosomal Dominant Polycystic Kidney Disease as part of its mission to develop therapies for patients suffering from chronic kidney disease.Explore more
Helex Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Helex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Helex has new funding data
Check if Helex has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Helex, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Helex had a recent Job posting/layoffs
Check out if Helex is spiking on competitors!
Product Launch: Get notified when Helex launches new products
Congratulate Masked Content for being promoted to Masked Content at Helex
Earning: See what the market has to say on Helex recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Helex as Masked Content
Find 3 more new buyers
Compare Similar Companies to Helex
Compare insights from companies similar to Helex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Helex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Helex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Helex.
Helex financials insights
Gather financial insights about Helex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Seed
$3.5M
Helex Tech Stack
A closer look at the technologies used by Helex
See more technologies
Helex News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Helex
Sign Up For FreeTo access detailed company insights
Helex is a biotechnology company headquartered in New York, New York, developing genomic medicines for kidney diseases. Founded in 2021, the company focuses on creating gene editing therapeutics specifically designed for renal indications. Helex combines proprietary lipid nanoparticle technology for targeted delivery to the kidney with its Epic-Cur... Read More
